Isseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes.

Simple item page
dc.contributor.authorJalleh, R.J.
dc.contributor.authorRayner, C.K.
dc.contributor.authorJones, K.L.
dc.contributor.authorHorowitz, M.
dc.date.issued2022
dc.descriptionComment
dc.description.abstractAbstract unavailable.
dc.description.statementofresponsibilityRyan J. Jalleh, Christopher K. Rayner, Karen L. Jones, Michael Horowitz
dc.identifier.citationThe Lancet Diabetes and Endocrinology, 2022; 10(9):610-611
dc.identifier.doi10.1016/s2213-8587(22)00193-0
dc.identifier.issn2213-8587
dc.identifier.issn2213-8595
dc.identifier.orcidJalleh, R.J. [0000-0003-4969-4771]
dc.identifier.orcidRayner, C.K. [0000-0002-5527-256X]
dc.identifier.orcidJones, K.L. [0000-0002-1155-5816]
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]
dc.identifier.urihttps://hdl.handle.net/2440/145892
dc.language.isoen
dc.publisherElsevier
dc.rights© 2025. Elsevier Inc. All rights reserved.
dc.source.urihttps://doi.org/10.1016/s2213-8587(22)00193-0
dc.subjectComment; insulin; a dual incretin receptor agonist; type 2 diabetes
dc.subject.meshHumans
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshGastric Inhibitory Polypeptide
dc.subject.meshHypoglycemic Agents
dc.subject.meshGlucagon-Like Peptide 1
dc.subject.meshIncretins
dc.subject.meshDipeptidyl-Peptidase IV Inhibitors
dc.subject.meshGlucagon-Like Peptide-1 Receptor
dc.titleIsseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes.
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Research Outputs